Skip to Main Content

Author Details

Jun Lu
Yale University
2005
36
31
PMIDPaper TitleJournal TitlePublished Year
35081358Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2.Cell Rep2022
36292918CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression.Int J Mol Sci2022
31874105The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas.J Clin Invest2020
29633759Publisher Correction: miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.Nat Commun2018
28926530Erratum: The microRNA miR-31 inhibits CD8<sup>+</sup> T cell function in chronic viral infection.Nat Immunol2017
28530712The microRNA miR-31 inhibits CD8<sup>+</sup> T cell function in chronic viral infection.Nat Immunol2017
27041566Increased miR-155-5p and reduced miR-148a-3p contribute to the suppression of osteosarcoma cell death.Oncogene2016
27373493Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis.Exp Hematol2016
27070706miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells.Cancer Cell2016
26832662miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells.Cancer Cell2016
25256711A functional screen identifies miRs that induce radioresistance in glioblastomas.Mol Cancer Res2014
23340433MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11.Nat Commun2013
24298054The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis.Genes Dev2013
22353710miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.Nat Commun2012
23079661Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia.Cancer Cell2012
21483750Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis.PLoS One2011
21408091MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells.PLoS One2011
20133587Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia.Proc Natl Acad Sci U S A2010
20550935Lineage-specific transcriptional regulation of DICER by MITF in melanocytes.Cell2010
20616003MicroRNA miR-125a controls hematopoietic stem cell number.Proc Natl Acad Sci U S A2010
19060901ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling.Nat Immunol2009
19903759Dicer1 functions as a haploinsufficient tumor suppressor.Genes Dev2009
19582159microRNA expression during trophectoderm specification.PLoS One2009
19759263MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer.Genes Dev2009
19483683Lin28 promotes transformation and is associated with advanced human malignancies.Nat Genet2009
19188669Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization.Blood2009
19188439MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes.Mol Cell Biol2009
18238902Dicer-dependent pathways regulate chondrocyte proliferation and differentiation.Proc Natl Acad Sci U S A2008
18832181Distinct microRNA expression profiles in acute myeloid leukemia with common translocations.Proc Natl Acad Sci U S A2008
19011087Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression.Proc Natl Acad Sci U S A2008
18539114MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors.Dev Cell2008
17401365Impaired microRNA processing enhances cellular transformation and tumorigenesis.Nat Genet2007
18056805MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia.Proc Natl Acad Sci U S A2007
17712037Altered microRNA expression in human heart disease.Physiol Genomics2007
15735639Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals.Nature2005
15944708MicroRNA expression profiles classify human cancers.Nature2005
  • 1 - 36 of 36

Recommended Authors

Jes??s Garc??a-L??pez
St. Jude Children's Research Hospital
Career Start Year 2012
Number of shared co-authors 0
Erik Ladewig
Memorial Sloan Kettering Cancer Center
Career Start Year 2012
Number of shared co-authors 0
Frederik Otzen Bagger
Center for Genomic Medicine, Rigshospitalet Copenhagen University Hospital
Career Start Year 2012
Number of shared co-authors 1
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Poching Liu
and Blood Institute, National Institutes of Health
Career Start Year 2010
Number of shared co-authors 0
Rajesha Rupaimoole
Harvard Medical School, Beth Israel Deaconess Medical Center
Career Start Year 2009
Number of shared co-authors 0
Bogumil Kaczkowski
RIKEN Center for Integrative Medical Sciences
Career Start Year 2009
Number of shared co-authors 0
Richard Mitter
The Francis Crick Institute
Career Start Year 2008
Number of shared co-authors 0
Raphaela Schwentner
Children's Cancer Research Institute
Career Start Year 2008
Number of shared co-authors 1
Collin Melton
Stanford University School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Loredana Martignetti
Institut Curie, PSL Research University
Career Start Year 2007
Number of shared co-authors 0
Praveen Sethupathy
Cornell University
Career Start Year 2006
Number of shared co-authors 0
Jingmin Shu
College of Health Solutions, Arizona State University
Career Start Year 2006
Number of shared co-authors 0
Christopher Y Park
NYU Robert I. Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 0
Su Ming Sun
Leiden University Medical Center
Career Start Year 2006
Number of shared co-authors 1
Antonio Sorrentino
Leibniz Institute for Immunotherapy (LIT)
Career Start Year 2005
Number of shared co-authors 0
Maggie Cam
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 1
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
P??l S??trom
Norwegian University of Science and Technology (NTNU)
Career Start Year 2004
Number of shared co-authors 1
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 2
Pavel Sumazin
Baylor College of Medicine
Career Start Year 2003
Number of shared co-authors 1
Emiliano Dalla
University of Udine
Career Start Year 2002
Number of shared co-authors 1
Ernesto Guccione
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2001
Number of shared co-authors 0
Jacqueline E Payton
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 2
Marco Mangone
Arizona State University
Career Start Year 2000
Number of shared co-authors 0
Jiayu Wen
Beijing University of Chinese Medicine
Career Start Year 1997
Number of shared co-authors 3
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 1
Muneesh Tewari
University of Michigan ann arbor
Career Start Year 1995
Number of shared co-authors 1
Alistair R R Forrest
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 1

Collaborators

Todd R Golub
Broad Institute of MIT and Harvard
Co-authored papers 18
Hao Zhang
Co-authored papers 7
Zejuan Li
Houston Methodist Hospital
Co-authored papers 6
Abdel G Elkahloun
National Human Genome Research Institute
Co-authored papers 4
Benjamin L Ebert
Co-authored papers 4
Hao Huang
Co-authored papers 4
Tyler Jacks
Co-authored papers 3
Carl R Walkley
Co-authored papers 3
Kolja Eppert
McGill University
Co-authored papers 2
Anjana Rao
La Jolla Institute for Immunology
Co-authored papers 2
David T Scadden
Co-authored papers 2
Gary D Bader
University of Toronto
Co-authored papers 2
Sek Won Kong
Boston Children's Hospital, Seoul National University, Seoul National University Hospital
Co-authored papers 2
Sadakatsu Ikeda
Tokyo Medical and Dental University Hospital
Co-authored papers 2
George Q Daley
Boston Children's Hospital, Harvard Medical School
Co-authored papers 2
Stuart H Orkin
Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers 2
Peter W Zandstra
Co-authored papers 2
Luigi Naldini
Vita-Salute San Raffaele University
Co-authored papers 2
Alistair M Chalk
Co-authored papers 2
William T Pu
Boston Children's Hospital, Harvard Medical School
Co-authored papers 2
Ruth Isserlin
University of Toronto
Co-authored papers 2
E Alejandro Sweet-Cordero
University of California San Francisco
Co-authored papers 2
Craig H Mermel
Co-authored papers 2
John E Dick
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Björn Nilsson
Co-authored papers 2
Natalya Bodyak
Beth Israel Deaconess Medical Center
Co-authored papers 1
Dipanjan Chowdhury
Dana-Farber Cancer Institute
Co-authored papers 1
Paul D Allen
Leeds Institute of Medical Research, University of Leeds
Co-authored papers 1
Dong-Er Zhang
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 1
Release 1.2